Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialAnthony V. Moorman, Gordon W. Dewald, Adele K. Fielding et al.|Blood|2006Cited by 746
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic respondersFrancesca Bonifazi, Michele Baccarani, Antonio De Vivo et al.|Blood|2001Cited by 319
Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemiaChristine J. Harrison, Anthony V. Moorman, Zoë J. Broadfield et al.|British Journal of Haematology|2004Cited by 234
Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocolIan Hann, Sue Richards, Ajay Vora et al.|British Journal of Haematology|2001Cited by 135
Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk‐stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172)Frank G. H. Hill, Osborn B. Eden, Sue Richards et al.|British Journal of Haematology|2003Cited by 80